Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032. Issue 2 (December 2015) - Taylor, Matthew; Antonia, Scott; Bendell, Johanna; Calvo, Emiliano; Jäger, Dirk; de Braud, Filippo; Ott, Patrick; Pietanza, M; Horn, Leora; Le, Dung; Morse, Michael; López-Martin, José; et al.